Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Cancer Pain × Radiotherapy, Intensity-Modulated × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Nasopharyngeal Carcinoma 55 Head and Neck Neoplasms 50 Squamous Cell Carcinoma of Head and Neck 49 Prostatic Neoplasms 32 Oropharyngeal Neoplasms 23 Carcinoma, Non-Small-Cell Lung 22 Carcinoma, Squamous Cell 21 Rectal Neoplasms 18 Breast Neoplasms 16 Neoplasm Metastasis 13 Glioblastoma 12 Carcinoma 12 Lung Neoplasms 11 Esophageal Neoplasms 11 Pancreatic Neoplasms 10 Glioma 10 Uterine Cervical Neoplasms 9 Sarcoma 9 Esophageal Squamous Cell Carcinoma 9 Radiation Injuries 8 Neoplasms 7 Nasopharyngeal Neoplasms 7 Mouth Neoplasms 7 Tongue Neoplasms 6 Laryngeal Neoplasms 6 Carcinoma, Hepatocellular 6 Brain Neoplasms 6 Astrocytoma 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Mesothelioma, Malignant 5

Interventions

Morphine 9 Methadone 6 Acetaminophen 5 Oxycodone 4 Lidocaine 4 Fentanyl 4 Ethanol 4 Transcutaneous Electric Nerve Stimulation 3 Buprenorphine 3 Acupuncture Therapy 3 Transcranial Direct Current Stimulation 2 Surveys and Questionnaires 2 Sodium Bicarbonate 2 Radiofrequency Ablation 2 Pharmaceutical Services 2 Ketamine 2 Control Groups 2 Analgesics, Opioid 2 oxycodone naloxone combination 1 nabiximols 1 incobotulinumtoxinA 1 Water 1 Tramadol 1 Therapeutic Touch 1 Telemedicine 1 Tapentadol 1 Sugars 1 Standard of Care 1 Ropivacaine 1 Radiotherapy, Intensity-Modulated 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04595032 2024-11-07

MAMETIC

National Cancer Institute, Naples

Cancer Pain, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡